Can a Montana resident get peptides by telehealth?
MCA 37-2-305 lets health care providers licensed in Montana provide services through telehealth when it is appropriate for the service, meets the standard of care, and complies with the licensing board's rules. It defines telehealth as audio, video, or other telecommunications technology, including audio-only communication, over a secure connection, and excludes fax or electronic messaging alone. The medical practice act, MCA 37-3-102, defines telemedicine to include store-and-forward technology, which covers information stored and reviewed later without the patient present in real time, and excludes e-mail, instant messaging conversations, and fax. Under Board of Medical Examiners rule ARM 24.156.813, a provider-patient relationship may be established by an in-person examination when the standard of care requires one, by consultation with a provider who has a documented relationship with the patient, or through telemedicine when the standard of care does not require an in-person encounter. The rule text was confirmed on the Cornell Legal Information Institute copy because the official page did not display it. The licensee must verify the patient's identity and obtain a sufficient medical history before prescribing. The prescriber must hold a Montana license under MCA 37-2-305. Montana law does not say whether a static questionnaire alone is enough. None of the peptides in this database are controlled substances. This record classifies asynchronous prescribing as allowed because the Board's rule lets the relationship be formed through telemedicine and the statute defines telemedicine to include store-and-forward technology with no real-time visit required. A service delivered only by e-mail, instant messaging, or electronic messaging alone is outside these definitions. [2] [3] [4]
How does the Montana pharmacy board treat compounding?
| Board | Montana Board of Pharmacy (Department of Labor and Industry, Business Standards Division) |
|---|---|
| Eligible substances | Follows the federal 503A framework |
The Montana Board of Pharmacy licenses pharmacies under MCA Title 37, chapter 7, and adopts rules in ARM Title 24, chapter 174. Part 7 of chapter 7 (MCA 37-7-701 and following) requires every out-of-state mail order pharmacy that ships prescriptions to Montana residents to register with the Board, submit a good-standing certificate from its home-state licensing authority, disclose ownership and officers, and identify the home-state pharmacist in charge of dispensing to Montana (MCA 37-7-703; ARM 24.174.1001 and 24.174.1003). Montana has no state bulks list; peptide eligibility follows the federal 503A framework. Montana's sterile compounding standards are in ARM 24.174.841 (sterile products), in subchapter 8 of the Board's rules (pharmacies), which requires compounding pharmacies to keep policies and procedures that comply with the spirit of USP chapters 795 and 797. The Board has proposed amending that rule and adopting new rules on nonsterile compounding, hazardous drug handling, and outsourcing facilities in MAR Notice No. 2026-131 (public hearing August 14, 2026); this record treats those changes as proposals until the Board adopts them. [1] [5] [6] [7] [8] [10]
Can you get compounded GLP-1s in Montana?
Rural Montana patients often rely on mail order; any out-of-state pharmacy mailing compounded GLP-1s into Montana must be registered as an out-of-state mail order pharmacy under MCA 37-7-703. [5] [13]
Prices by channel: semaglutide cost, tirzepatide cost.
Approvals, shortage history, and prices for every GLP-1 we track are on the GLP-1 hub.
What is the legal access path in Montana?
Access options
Prescriber licensed in Montana, in person or by telehealth
Telehealth prescribing of non-controlled peptides is permitted in Montana. A prescriber may prescribe without a live visit (asynchronous care) when it meets the standard of care.
Check the dispensing pharmacy against the board's license lookup before paying, including out-of-state mail-order pharmacies.
Branded GLP-1 through a retail or manufacturer pharmacy
FDA approved semaglutide and tirzepatide are available by prescription. Compounded GLP-1 limited; see the GLP-1 section for why.
CJC-1295 / Ipamorelin from Bodybuilding Peptides
SponsoredPartner lists from $220/month
Tesamorelin / Ipamorelin from Bodybuilding Peptides
SponsoredPartner lists from $274/month
Semax / Selank from Bodybuilding Peptides
SponsoredPartner lists from $274/month
We may earn a commission from these links.
Prices are the partner's own and are not verified by PeptideAgent. You answer health questions after checkout, and the partner's clinician decides whether to prescribe.
Unsponsored access paths are checked against public regulatory records. Sponsored offers are the partner's and are labeled. Products labeled research use only are never listed.
Find a provider in Montana
What you'll actually find in Montana, and how to check
Licensed compounding pharmacies, clinics, and telehealth prescribers openly offer many unapproved peptides, and prescribers write prescriptions for them. [17] [18] [19]
No FDA oversight of the specific product: FDA does not check a compounded drug's safety, effectiveness, or quality before it is sold. [20]
What Montana has done
PeptideAgent has not found a board or legislative action on peptides in Montana.
Other states have acted:
- On August 19, 2026, Mississippi's medical, nursing, and pharmacy boards said no licensed provider may prescribe, recommend, supply, or administer a peptide that is not FDA approved, and that a consent form does not remove the provider's liability. [22] Mississippi law
- Louisiana acted by statute: Act 374, in effect August 1, 2026, bars its licensing boards from prohibiting peptides only when they come from a pharmacy or outsourcing facility that complies with federal compounding law. It does not make any peptide eligible to compound. [23] [24] Louisiana law
Checking the prescriber
Telehealth prescribing of non-controlled peptides is permitted in Montana. A prescriber may prescribe without a live visit (asynchronous care) when it meets the standard of care. [2] [3] [4] The telehealth rule in full.
Checking the pharmacy
Look the pharmacy up yourself before you pay, including an out-of-state mail-order pharmacy. The pharmacy regulator is the Montana Board of Pharmacy (Department of Labor and Industry, Business Standards Division); its license search: FDA BeSafeRx: state board of pharmacy license lookups. [21]
If you're going ahead anyway
These steps lower some risks. They do not make a compounded product safe, and FDA has not reviewed it. [20]
They do not change a peptide's legal status either. That depends on the peptide: for a withdrawn nomination such as BPC-157 or TB-500, a 503A pharmacy has no federal basis to compound it from bulk, with or without a prescription, while a few Category 1 substances, such as NAD+ and glutathione, are compounded under FDA's interim policy, with conditions. Each peptide page gives its status. [11] [25] [26]
Check the pharmacy's license. Look the pharmacy up yourself on your state board of pharmacy's license search; FDA's BeSafeRx page links every state's. If the pharmacy is not listed, or is not licensed in your state, do not use it. [21] [27] [28]
What a legitimate prescription and consult look like. Federal law lets a pharmacy compound only for an identified patient on a valid prescription. A legitimate prescriber is licensed in the state where you are, evaluates you, and tells you the drug is compounded and not FDA approved, and a telehealth company should say which pharmacy compounds it. A seller that needs no prescription, or a pharmacy with no pharmacist to answer questions, is a warning sign. [19] [28] [29]
Why this is safer than a research-use-only product. A state-licensed pharmacy answers to its state board and has a pharmacist you can reach. A product labeled "research use only" or "not for human consumption" has neither, and FDA treats such products sold for people as unapproved drugs. In a 2024 study of semaglutide sold online without a prescription, half of six orders never arrived, and every vial that did was rated probably substandard or falsified, held more drug than its label said, and contained endotoxin. Black-market growth peptides have also contained modified molecules the label did not name. Safer is not safe: compounded drugs can also be contaminated or have too much or too little active ingredient. [20] [30] [31] [32] [33] [34]
Check for:
- A 503A pharmacy licensed in your state (your state board of pharmacy publishes license lookups). [20]
- A real evaluation by a licensed prescriber, not just an online form.
- A certificate of analysis for the specific batch.
Questions to ask
- Pharmacy: What is your license number, and are you licensed in my state? Then check it yourself on the state board's site. [21]
- Telehealth company: Which pharmacy compounds and ships this, and is it a 503A pharmacy or a 503B outsourcing facility? [19]
- Pharmacy: Is this made for me on a prescription written in my name? [29]
- Prescriber: Are you licensed where I am, and will you evaluate me yourself rather than rely on a questionnaire? [19] [28]
- Anyone offering it: Does anyone call it "FDA approved", "generic", or from an "FDA-approved pharmacy"? None of these is true of a compounded drug, so the claim is a red flag. [19]
What is offered for a specific peptide, and what FDA found, is on each peptide page.
Is it legal to buy research peptides in Montana?
The Montana Food, Drug, and Cosmetic Act (MCA Title 50, chapter 31) prohibits selling adulterated or misbranded drugs, and MCA Title 37, chapter 7 restricts dispensing of prescription drugs to licensed pharmacies. [1] [5] [9] [14]
Peptide-specific notes for Montana
No peptide-specific rule identified for this jurisdiction. The general compounding and telehealth rules above apply, and the federal record covers semaglutide, tirzepatide, and BPC-157.
Frequently asked questions
Can I get a GLP-1 prescription in Montana through telehealth?
Yes, from a Montana-licensed prescriber. MCA 37-2-305 authorizes telehealth, including audio-only care, and Board rule ARM 24.156.813 lets a relationship be established through telemedicine when the standard of care does not require an in-person visit. Fax, e-mail, or instant messaging used by itself does not count as telehealth or telemedicine. Semaglutide and tirzepatide are not controlled substances. [2] [3] [4]
Does Montana count a phone call as telehealth?
Yes. Montana's statutory definition of telehealth expressly includes audio-only communication over a secure connection, though the prescriber must still meet the standard of care for the condition being treated. [2]
Can an out-of-state pharmacy mail compounded peptides to me in Montana?
Only if it is registered with the Montana Board of Pharmacy as an out-of-state mail order pharmacy under MCA 37-7-703, which requires a home-state good-standing certificate and a named pharmacist in charge of Montana dispensing. [5] [6]
Can a Montana pharmacy compound BPC-157?
Only under a draft federal policy, and only within strict limits. On October 28, 2026 HHS released a draft enforcement discretion policy saying it will not take enforcement action against a state-licensed pharmacy that compounds BPC-157 as a single-ingredient product by an allowed route, on a patient-specific prescription, from an FDA-registered manufacturer's substance with a tested certificate of analysis, with serious adverse events reported to FDA. BPC-157 is still not FDA approved or on the 503A bulks list, the policy is not binding and HHS may revisit it, and blends such as Wolverine are not covered. FDA's drug center recommended against listing BPC-157; the advisory committee voted in favor (HHS policy, Appendix B). State law still applies: Montana has no state bulks list; peptide eligibility follows the federal 503A framework. [10] [11] [12] [15] [16]
Sources
Numbered citations above point to these primary sources: the state statute or rule, the pharmacy board, federal FDA guidance, and the FDA warning letters and studies behind what is offered.
- [1]Montana Board of Pharmacy
- [2]MCA 37-2-305, Telehealth services, rulemaking authority
- [3]MCA 37-3-102, Definitions (practice of medicine, store-and-forward technology, telemedicine)
- [4]ARM 24.156.813, Practice requirements for physicians and physician assistants using telemedicine (official site; rule text confirmed on the Cornell LII copy)
- [5]MCA 37-7-703, Out-of-state mail order pharmacy registration requirements
- [6]ARM 24.174.1001, Registration of out-of-state mail service pharmacies
- [7]ARM 24.174.841, Sterile products
- [8]Montana Board of Pharmacy, MAR Notice No. 2026-131, proposed amendment of ARM 24.174.841 and adoption of compounding rules
- [9]MCA Title 50, chapter 31, Food, drugs, and cosmetics
- [10]FDA: Section 503A of the Federal Food, Drug, and Cosmetic ActFDA
Cite this page
Free to cite and quote with a link. Data is licensed CC BY 4.0 with attribution to PeptideAgent.
- APA style
PeptideAgent. (2026, October 28). Are peptides legal in Montana?. https://peptideagent.ai/legal/montana- HTML link
<a href="https://peptideagent.ai/legal/montana">Are peptides legal in Montana?</a>, PeptideAgent, updated October 28, 2026.